Literature DB >> 3039503

Activation of transforming potential of the human insulin receptor gene.

L H Wang, B Lin, S M Jong, D Dixon, L Ellis, R A Roth, W J Rutter.   

Abstract

A retrovirus containing part of the human insulin receptor (hIR) gene was constructed by replacing ros sequences in the avian sarcoma virus UR2 with hIR cDNA sequences coding for 46 amino acids of the extracellular domain and the entire transmembrane and cytoplasmic domains of the beta subunit of hIR. The resulting virus, named UIR, contains the hIR sequence fused to the 5' portion of the UR2 gag gene coding for p19. UIR is capable of transforming chicken embryo fibroblasts and promoting formation of colonies in soft agar; however, it does not form tumors in vivo. A variant that arose from the parental UIR is capable of efficiently inducing sarcomas in vivo. UIR-transformed cells exhibit higher rates of glucose uptake and growth than normal cells. The 4-kilobase UIR genome codes for a membrane-associated, glycosylated gag-hIR fusion protein of 75 kDa designated P75gag-hir. P75gag-hir contains a protein tyrosine kinase activity that is capable of undergoing autophosphorylation and of phosphorylating foreign substrates in vitro; it is phosphorylated at both serine and tyrosine residues in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039503      PMCID: PMC298935          DOI: 10.1073/pnas.84.16.5725

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Rapid transformation of cells by Rous sarcoma virus.

Authors:  H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

2.  From c-fos to v-fos.

Authors:  I M Verma
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

3.  The erbB gene of avian erythroblastosis virus is a member of the src gene family.

Authors:  T Yamamoto; T Nishida; N Miyajima; S Kawai; T Ooi; K Toyoshima
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

4.  Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

Authors:  A Hampe; M Gobet; C J Sherr; F Galibert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

6.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

7.  Characterization of protein kinase activity associated with the transforming gene product of Fujinami sarcoma virus.

Authors:  R A Feldman; T Hanafusa; H Hanafusa
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

8.  A fps gene without gag gene sequences transforms cells in culture and induces tumors in chickens.

Authors:  D A Foster; H Hanafusa
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

9.  Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation.

Authors:  R Prywes; J G Foulkes; N Rosenberg; D Baltimore
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

10.  The transforming protein P68gag-ros of avian sarcoma virus UR2 is a transmembrane protein with the gag portion protruding extracellularly.

Authors:  S M Jong; L H Wang
Journal:  Oncogene Res       Date:  1987-06
View more
  15 in total

1.  Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.

Authors:  S M Jong; L H Wang
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 2.  Biological electron transfer.

Authors:  C C Moser; C C Page; R Farid; P L Dutton
Journal:  J Bioenerg Biomembr       Date:  1995-06       Impact factor: 2.945

3.  Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Authors:  M Kaleko; W J Rutter; A D Miller
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  Proteolytic generation of constitutive tyrosine kinase activity of the human insulin receptor.

Authors:  J J Hsuan; J Downward; S Clark; M D Waterfield
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

5.  Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins.

Authors:  Q K Zhang; S Boast; K de los Santos; M Begemann; S P Goff
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras.

Authors:  B Poon; D Dixon; L Ellis; R A Roth; W J Rutter; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Ala-->Gly mutation in the putative catalytic loop confers temperature sensitivity on Ros, insulin receptor, and insulin-like growth factor I receptor protein-tyrosine kinases.

Authors:  J Chen; T Hanafusa; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions.

Authors:  D Liu; C S Zong; L H Wang
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.